ArticleInternational urology and nephrology2021

Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer.

Katharina Möller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.